Literature DB >> 14674702

Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts.

Jianhua Cui1, Dipak K Das, Aldo Bertelli, Arpad Tosaki.   

Abstract

The study aimed to examine whether L-carnitine and its derivatives, acetyl-L-carnitine and propionyl-L-carnitine, were equally effective and able to improve postischemic cardiac function, reduce the incidence of reperfusion-induced ventricular fibrillation, infarct size, and apoptotic cell death in ischemic/reperfused isolated rat hearts. There are several studies indicating that L-carnitine, a naturally occurring amino acid and an essential cofactor, can improve mechanical function and substrate metabolism not only in hypertrophied or failing myocardium but also in ischemic/reperfused hearts. The effects of L-carnitine, acetyl-L-carnitine, and propionyl-L-carnitine, on the recovery of heart function, incidence of reperfusion-induced ventricular fibrillation (VF), infarct size, and apoptotic cell death after 30 min ischemia followed by 120 min reperfusion were studied in isolated working rat hearts. Hearts were perfused with various concentrations of L-carnitine (0.5 and 5 mM), acetyl-L-carnitine (0.5 and 5 mM), and propionyl-L-carnitine (0.05, 0.5, and 5 mM), respectively, for 10 min before the induction of ischemia. Postischemic recovery of CF, AF, and LVDP was significantly improved in all groups perfused with 5 mM of L-carnitine, acetyl-L-carnitine, and propionyl-L-carnitine. Significant postischemic ventricular recovery was noticed in the hearts perfused with 0.5 mM of propionyl-L-carnitine, but not with the same concentration of L-carnitine or L-acetyl carnitine. The incidence of reperfusion VF was reduced from its control value of 90 to 10% (p < 0.05) in hearts perfused with 5 mM of propionyl-L-carnitine only. Other doses of various carnitines failed to reduce the incidence of VF. The protection in CF, AF, LVDP, and VF reflected in a reduction in infarct size and apoptotic cell death in hearts treated with various concentrations of carnitine derivatives. The difference between effectiveness of various carnitines on the recovery of postischemic myocardium may be explained by different membrane permeability properties of carnitine and its derivatives.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14674702     DOI: 10.1023/a:1027368018064

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart.

Authors:  R Ferrari; E Pasini; E Condorelli; A Boraso; R Lisciani; A Marzo; O Visiou
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

Review 2.  Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle.

Authors:  J R Neely; H E Morgan
Journal:  Annu Rev Physiol       Date:  1974       Impact factor: 19.318

3.  Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism.

Authors:  A K Jonassen; B K Brar; O D Mjøs; M N Sack; D S Latchman; D M Yellon
Journal:  J Mol Cell Cardiol       Date:  2000-05       Impact factor: 5.000

4.  Beneficial effects of propionyl L-carnitine on sarcolemmal changes in congestive heart failure due to myocardial infarction.

Authors:  R Sethi; K S Dhalla; P K Ganguly; R Ferrari; N S Dhalla
Journal:  Cardiovasc Res       Date:  1999-06       Impact factor: 10.787

5.  Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine.

Authors:  M C Mutomba; H Yuan; M Konyavko; S Adachi; C B Yokoyama; V Esser; J D McGarry; B M Babior; R A Gottlieb
Journal:  FEBS Lett       Date:  2000-07-28       Impact factor: 4.124

6.  Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis.

Authors:  A Leri; Y Liu; P P Claudio; J Kajstura; X Wang; S Wang; P Kang; A Malhotra; P Anversa
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

7.  Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.

Authors:  A Tosaki; A Hellegouarch
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

8.  Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.

Authors:  G L Bartels; W J Remme; M Pillay; D H Schönfeld; D A Kruijssen
Journal:  Am J Cardiol       Date:  1994-07-15       Impact factor: 2.778

9.  Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia.

Authors:  K A Yamada; J McHowat; G X Yan; K Donahue; J Peirick; A G Kléber; P B Corr
Journal:  Circ Res       Date:  1994-01       Impact factor: 17.367

10.  An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia.

Authors:  N Maulik; M Sato; B D Price; D K Das
Journal:  FEBS Lett       Date:  1998-06-16       Impact factor: 4.124

View more
  9 in total

1.  Short term administration of L-carnitine can be detrimental to the ischemic heart.

Authors:  Moslem Najafi; Alireza Garjani
Journal:  Adv Pharm Bull       Date:  2013-12-23

2.  Resistance to reperfusion injury following short term postischemic administration of natural honey in globally ischemic isolated rat heart.

Authors:  Haleh Vaez; Mehrban Samadzadeh; Fahimeh Zahednezhad; Moslem Najafi
Journal:  Adv Pharm Bull       Date:  2012-08-15

3.  The protective effect of L-carnitine on ischemia-reperfusion heart.

Authors:  Jiang Xie; Qiutang Zeng; Le Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Acetyl-L-carnitine supplementation reverses the age-related decline in carnitine palmitoyltransferase 1 (CPT1) activity in interfibrillar mitochondria without changing the L-carnitine content in the rat heart.

Authors:  Luis A Gómez; Shi-Hua D Heath; Tory M Hagen
Journal:  Mech Ageing Dev       Date:  2012-02-01       Impact factor: 5.432

Review 5.  Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Authors:  Carmen Mingorance; Rosalía Rodríguez-Rodríguez; María Luisa Justo; María Alvarez de Sotomayor; María Dolores Herrera
Journal:  Vasc Health Risk Manag       Date:  2011-03-28

Review 6.  Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2013-03-19       Impact factor: 5.614

7.  Potential Effect of L-Carnitine on the Prevention of Myocardial Injury after Coronary Artery Bypass Graft Surgery.

Authors:  Farzaneh Dastan; Azita Hajhossein Talasaz; Mojtaba Mojtahedzadeh; Abbasali Karimi; Abbas Salehiomran; Payvand Bina; Arash Jalali; Zahra Aghaie
Journal:  J Tehran Heart Cent       Date:  2015-04-03

8.  Effects of Postconditioning, Preconditioning and Perfusion of L-carnitine During Whole Period of Ischemia/ Reperfusion on Cardiac Hemodynamic Functions and Myocardial Infarction Size in Isolated Rat Heart.

Authors:  Moslem Najafi
Journal:  Iran J Basic Med Sci       Date:  2013-04       Impact factor: 2.699

9.  Effects of Postconditioning, Preconditioning and Perfusion of L-carnitine During Whole Period of Ischemia/ Reperfusion on Cardiac Hemodynamic Functions and Myocardial Infarction Size in Isolated Rat Heart.

Authors:  Moslem Najafi
Journal:  Iran J Basic Med Sci       Date:  2013-04       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.